Studies find markers for CVD-related deaths in type 2 diabetes

09/15/2011 | MedPage Today (free registration)

Increased levels of peroxiredoxin-4 antioxidants were associated with a higher rate of cardiovascular-related and all-cause mortality over a 9.8-year follow-up on Dutch patients with type 2 diabetes, according to a study reported at the European Association for the Study of Diabetes meeting. A separate study showed high rates of resistin proteins had the same effects.

View Full Article in:

MedPage Today (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY